1. How to use GuruFocus - Tutorials
  2. What Is in the GuruFocus Premium Membership?
  3. A DIY Guide on How to Invest Using Guru Strategies
insider
insider
Articles 

Longwood Capital Partners LLC Buys Milestone Pharmaceuticals Inc, BELLUS Health Inc, Reata Pharmaceuticals Inc, Sells Iovance Biotherapeutics Inc, Adverum Biotechnologies Inc, Biohaven Pharmaceutical Holding Co

Portola Valley, CA, based Investment company Longwood Capital Partners LLC (Current Portfolio) buys Milestone Pharmaceuticals Inc, BELLUS Health Inc, Reata Pharmaceuticals Inc, Karyopharm Therapeutics Inc, CRISPR Therapeutics AG, sells Iovance Biotherapeutics Inc, Adverum Biotechnologies Inc, Biohaven Pharmaceutical Holding Co, Veracyte Inc, Athenex Inc during the 3-months ended 2019Q3, according to the most recent filings of the investment company, Longwood Capital Partners LLC. As of 2019Q3, Longwood Capital Partners LLC owns 30 stocks with a total value of $138 million. These are the details of the buys and sells.

For the details of Longwood Capital Partners LLC's stock buys and sells, go to https://www.gurufocus.com/guru/longwood+capital+partners+llc/current-portfolio/portfolio

These are the top 5 holdings of Longwood Capital Partners LLC
  1. Kadmon Holdings Inc (KDMN) - 6,412,500 shares, 11.74% of the total portfolio. Shares reduced by 15.82%
  2. Iovance Biotherapeutics Inc (IOVA) - 727,500 shares, 9.62% of the total portfolio. Shares reduced by 70.02%
  3. Arvinas Inc (ARVN) - 566,500 shares, 8.87% of the total portfolio. Shares added by 2.81%
  4. SPDR S&P Biotech ETF (XBI) - 150,000 shares, 8.31% of the total portfolio.
  5. Arrowhead Pharmaceuticals Inc (ARWR) - 387,500 shares, 7.93% of the total portfolio. Shares reduced by 19.02%
New Purchase: Milestone Pharmaceuticals Inc (MIST)

Longwood Capital Partners LLC initiated holding in Milestone Pharmaceuticals Inc. The purchase prices were between $15.67 and $25.96, with an estimated average price of $19.77. The stock is now traded at around $17.53. The impact to a portfolio due to this purchase was 5.01%. The holding were 369,500 shares as of .

New Purchase: BELLUS Health Inc (BLU)

Longwood Capital Partners LLC initiated holding in BELLUS Health Inc. The purchase prices were between $6.24 and $8.84, with an estimated average price of $7.67. The stock is now traded at around $5.76. The impact to a portfolio due to this purchase was 3.64%. The holding were 785,000 shares as of .

New Purchase: Reata Pharmaceuticals Inc (RETA)

Longwood Capital Partners LLC initiated holding in Reata Pharmaceuticals Inc. The purchase prices were between $71.26 and $95.75, with an estimated average price of $84.89. The stock is now traded at around $187.48. The impact to a portfolio due to this purchase was 2.63%. The holding were 45,000 shares as of .

New Purchase: Karyopharm Therapeutics Inc (KPTI)

Longwood Capital Partners LLC initiated holding in Karyopharm Therapeutics Inc. The purchase prices were between $5.66 and $11.85, with an estimated average price of $9.03. The stock is now traded at around $15.09. The impact to a portfolio due to this purchase was 1.66%. The holding were 237,500 shares as of .

New Purchase: Amarin Corp PLC (AMRN)

Longwood Capital Partners LLC initiated holding in Amarin Corp PLC. The purchase prices were between $13.89 and $23.16, with an estimated average price of $17.5. The stock is now traded at around $21.49. The impact to a portfolio due to this purchase was 1.1%. The holding were 100,000 shares as of .

New Purchase: Kura Oncology Inc (KURA)

Longwood Capital Partners LLC initiated holding in Kura Oncology Inc. The purchase prices were between $14.75 and $20.87, with an estimated average price of $17.8. The stock is now traded at around $14.95. The impact to a portfolio due to this purchase was 1.05%. The holding were 95,000 shares as of .

Added: CRISPR Therapeutics AG (CRSP)

Longwood Capital Partners LLC added to a holding in CRISPR Therapeutics AG by 69.62%. The purchase prices were between $40.99 and $52.56, with an estimated average price of $47.76. The stock is now traded at around $55.00. The impact to a portfolio due to this purchase was 1.64%. The holding were 134,000 shares as of .

Sold Out: Adverum Biotechnologies Inc (ADVM)

Longwood Capital Partners LLC sold out a holding in Adverum Biotechnologies Inc. The sale prices were between $5.24 and $15.89, with an estimated average price of $11.26.

Sold Out: Biohaven Pharmaceutical Holding Co Ltd (BHVN)

Longwood Capital Partners LLC sold out a holding in Biohaven Pharmaceutical Holding Co Ltd. The sale prices were between $37.38 and $49.47, with an estimated average price of $42.24.

Sold Out: Athenex Inc (ATNX)

Longwood Capital Partners LLC sold out a holding in Athenex Inc. The sale prices were between $12.17 and $21, with an estimated average price of $16.36.

Sold Out: ViewRay Inc (VRAY)

Longwood Capital Partners LLC sold out a holding in ViewRay Inc. The sale prices were between $2.9 and $9.56, with an estimated average price of $5.93.

Sold Out: Dicerna Pharmaceuticals Inc (DRNA)

Longwood Capital Partners LLC sold out a holding in Dicerna Pharmaceuticals Inc. The sale prices were between $12.71 and $15.78, with an estimated average price of $14.3.

Sold Out: Immunomedics Inc (IMMU)

Longwood Capital Partners LLC sold out a holding in Immunomedics Inc. The sale prices were between $12.59 and $17.44, with an estimated average price of $14.67.



Here is the complete portfolio of Longwood Capital Partners LLC. Also check out:

1. Longwood Capital Partners LLC's Undervalued Stocks
2. Longwood Capital Partners LLC's Top Growth Companies, and
3. Longwood Capital Partners LLC's High Yield stocks
4. Stocks that Longwood Capital Partners LLC keeps buying

Rating: 0.0/5 (0 votes)

Comments

Please leave your comment:



Performances of the stocks mentioned by insider


User Generated Screeners


pjmason14Momentum
pascal.van.garsseHigh FCF-M2
kosalmmuse6
kosalmmuseBest one1
DBrizanall 2019Feb26
kosalmmuseBest one
DBrizanall 2019Feb25
kosalmmuseNice
kosalmmusehan
MsDale*52-Week Low
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)